International Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025

International Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025

The 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop is an advanced two-day educational event dedicated to the latest innovations in immune-based treatments for multiple myeloma. This workshop delivers in-depth scientific updates alongside practical, case-driven discussions to help participants optimize clinical outcomes.

What You Will Learn

• Latest clinical trial data on CAR T-cell therapies targeting BCMA and GPRC5D

• Advances in bispecific antibodies and T-cell engagers, including teclistamab, elranatamab, talquetamab, and others

• Strategies to manage toxicities such as cytokine release syndrome, cytopenias, and organ-specific complications

• Emerging therapies: allogeneic CAR T, CAR-NK cells, dual antigen targeting, and trispecific antibodies

• Approaches to overcome resistance and enhance treatment response through combination regimens and immune modulation

Event Details

• Dates: March 28–29, 2025

• Location: Boston Marriott Long Wharf, Boston, Massachusetts

Who Should Attend
This workshop is ideal for:

• Hematologists and oncologists treating multiple myeloma

• Clinical researchers and trial investigators in immune therapy

• Advanced practice providers and pharmacists involved in immune effector cell therapy care

• Industry professionals and academic experts interested in translating research into clinical practice

Why Attend

• Gain comprehensive insights into the latest immune effector cell therapy developments

• Learn practical management strategies for complex therapy-related toxicities

• Network with global leaders and peers in the myeloma research community

• Apply cutting-edge scientific knowledge directly to patient care

• IEC2025Program.pdf
  SESSION 1 CLINICAL UPDATES ON CAR T CELLS.mp4
  SESSION 2 CLINICAL UPDATES ON BISPECIFIC ABS TCE’S.mp4
  SESSION 3 PRACTICAL CONSIDERATIONS FOR IMMUNE THERAPY.mp4
  SESSION 4 NOVEL APPROACHES IN THE CLINIC.mp4
  SESSION 5 MANAGING TOXICITIES OF T CELL ENGAGING THERAPIES.mp4
  SESSION 6 CORRELATES OF RESPONSE AND RESISTANCE.mp4
  SESSION 7 STRATEGIES TO IMPROVE IMMUNE EFFECTOR CELL THERAPIES.mp4
  SESSION 8 KEY QUESTIONS IN IMMUNE THERAPY.mp4
  WORKSHOP ON SECONDARY MALIGNANCIES AND NON-RELAPSE MORTALITY.mp4